• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fast TILs——一种用于非小细胞肺癌中TILs高效评估的流程。

Fast TILs-A pipeline for efficient TILs estimation in non-small cell Lung cancer.

作者信息

Shvetsov Nikita, Sildnes Anders, Tafavvoghi Masoud, Busund Lill-Tove Rasmussen, Dalen Stig Manfred, Møllersen Kajsa, Bongo Lars Ailo, Kilvær Thomas Karsten

机构信息

Department of Computer Science, UiT The Arctic University of Norway, Tromsø, Norway.

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

出版信息

J Pathol Inform. 2025 Mar 12;17:100437. doi: 10.1016/j.jpi.2025.100437. eCollection 2025 Apr.

DOI:10.1016/j.jpi.2025.100437
PMID:40230809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11994347/
Abstract

The prognostic relevance of tumor-infiltrating lymphocytes (TILs) in non-small cell Lung cancer (NSCLC) is well-established. However, manual TIL quantification in hematoxylin and eosin (H&E) whole slide images (WSIs) is laborious and prone to variability. To address this, we aim to develop and validate an automated computational pipeline for the quantification of TILs in WSIs of NSCLC. Such a solution in computational pathology can accelerate TIL evaluation, thereby standardizing the prognostication process and facilitating personalized treatment strategies. We develop an end-to-end automated pipeline for TIL estimation in Lung cancer WSIs by integrating a patch extraction approach based on hematoxylin component filtering with a machine learning-based patch classification and cell quantification method using the HoVer-Net model architecture. Additionally, we employ randomized patch sampling to further reduce the processed patch amount. We evaluate the effectiveness of the patch sampling procedure, the pipeline's ability to identify informative patches and computational efficiency, and the clinical value of produced scores using patient survival data. Our pipeline demonstrates the ability to selectively process informative patches, achieving a balance between computational efficiency and prognostic integrity. The pipeline filtering excludes approximately 70% of all patch candidates. Further, only 5% of eligible patches are necessary to retain the pipeline's prognostic accuracy (c-index = 0.65), resulting in a linear reduction of the total computational time compared to the filtered patch subset analysis. The pipeline's TILs score has a strong association with patient survival and outperforms traditional CD8 immunohistochemical scoring (c-index = 0.59). Kaplan-Meier analysis further substantiates the TILs score's prognostic value. This study introduces an automated pipeline for TIL evaluation in Lung cancer WSIs, providing a prognostic tool with potential to improve personalized treatment in NSCLC. The pipeline's computational advances, particularly in reducing processing time, and clinical relevance demonstrate a step forward in computational pathology.

摘要

肿瘤浸润淋巴细胞(TILs)在非小细胞肺癌(NSCLC)中的预后相关性已得到充分证实。然而,在苏木精和伊红(H&E)全切片图像(WSIs)中手动定量TILs既费力又容易出现变异性。为了解决这个问题,我们旨在开发并验证一种用于NSCLC的WSIs中TILs定量的自动化计算流程。计算病理学中的这样一种解决方案可以加速TIL评估,从而使预后过程标准化并促进个性化治疗策略。我们通过将基于苏木精成分过滤的补丁提取方法与使用HoVer-Net模型架构的基于机器学习的补丁分类和细胞定量方法相结合,开发了一种用于肺癌WSIs中TIL估计的端到端自动化流程。此外,我们采用随机补丁采样来进一步减少处理的补丁数量。我们评估了补丁采样程序的有效性、该流程识别信息丰富补丁的能力和计算效率,以及使用患者生存数据产生的分数的临床价值。我们的流程展示了选择性处理信息丰富补丁的能力,在计算效率和预后完整性之间取得了平衡。流程过滤排除了所有补丁候选物的约70%。此外,仅需5%的合格补丁就能保持流程的预后准确性(c指数 = 0.65),与过滤后的补丁子集分析相比,总计算时间呈线性减少。该流程的TILs分数与患者生存密切相关,并且优于传统的CD8免疫组织化学评分(c指数 = 0.59)。Kaplan-Meier分析进一步证实了TILs分数的预后价值。本研究介绍了一种用于肺癌WSIs中TIL评估的自动化流程,提供了一种有可能改善NSCLC个性化治疗的预后工具。该流程的计算进展,特别是在减少处理时间方面,以及临床相关性表明了计算病理学向前迈进了一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/23754aea8420/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/daa092faa6af/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/54f62b1cb93a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/4a54a7fe8d56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/4d8511ba44ac/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/71c9d616b3f1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/23754aea8420/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/daa092faa6af/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/54f62b1cb93a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/4a54a7fe8d56/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/4d8511ba44ac/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/71c9d616b3f1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de8e/11994347/23754aea8420/gr6.jpg

相似文献

1
Fast TILs-A pipeline for efficient TILs estimation in non-small cell Lung cancer.Fast TILs——一种用于非小细胞肺癌中TILs高效评估的流程。
J Pathol Inform. 2025 Mar 12;17:100437. doi: 10.1016/j.jpi.2025.100437. eCollection 2025 Apr.
2
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images.一种用于量化全切片图像中肿瘤浸润淋巴细胞的实用机器学习方法。
Cancers (Basel). 2022 Jun 16;14(12):2974. doi: 10.3390/cancers14122974.
3
Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.深度学习卷积神经网络在原发性黑色素瘤中对肿瘤浸润淋巴细胞的识别。
Am J Pathol. 2023 Dec;193(12):2099-2110. doi: 10.1016/j.ajpath.2023.08.013. Epub 2023 Sep 20.
4
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.利用常规 H&E 切片评估肿瘤浸润淋巴细胞可预测接受手术切除的非小细胞肺癌患者的生存情况。
Hum Pathol. 2018 Sep;79:188-198. doi: 10.1016/j.humpath.2018.05.017. Epub 2018 Jun 6.
5
AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection.基于人工智能的肿瘤浸润淋巴细胞评分系统用于评估肝切除患者的肝癌预后
JHEP Rep. 2024 Nov 12;7(2):101270. doi: 10.1016/j.jhepr.2024.101270. eCollection 2025 Feb.
6
Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.基于深度学习的乳腺癌组织病理学图像和多组学数据中肿瘤浸润淋巴细胞的特征分析。
JCO Clin Cancer Inform. 2020 May;4:480-490. doi: 10.1200/CCI.19.00126.
7
A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.一种新的肿瘤浸润淋巴细胞丰度数字评分可预测口腔鳞状细胞癌无病生存。
Sci Rep. 2019 Sep 16;9(1):13341. doi: 10.1038/s41598-019-49710-z.
8
Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer.基于病理学的深度学习特征用于预测膀胱癌的基底型和管腔型亚型
BMC Cancer. 2025 Feb 20;25(1):310. doi: 10.1186/s12885-025-13688-x.
9
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC.基于机器学习的标准组织学图像中肿瘤浸润淋巴细胞评估与 NSCLC 患者免疫治疗结局的相关性。
JAMA Oncol. 2023 Jan 1;9(1):51-60. doi: 10.1001/jamaoncol.2022.4933.
10
Pathomics Image Analysis of Tumor Infiltrating Lymphocytes (TILs) in Colon Cancer.结肠癌中肿瘤浸润淋巴细胞(TILs)的病理组学图像分析
Res Sq. 2025 Apr 1:rs.3.rs-6173056. doi: 10.21203/rs.3.rs-6173056/v1.

本文引用的文献

1
Foundation models in ophthalmology.眼科的基础模型。
Br J Ophthalmol. 2024 Sep 20;108(10):1341-1348. doi: 10.1136/bjo-2024-325459.
2
A Real-world Dataset and Benchmark For Foundation Model Adaptation in Medical Image Classification.用于医学图像分类中基础模型自适应的真实世界数据集和基准
Sci Data. 2023 Sep 2;10(1):574. doi: 10.1038/s41597-023-02460-0.
3
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial.基于机器学习的免疫表型与可切除 NSCLC 中的 STK11/KEAP1 共突变和预后相关:TNM-I 试验的子研究。
Ann Oncol. 2023 Jul;34(7):578-588. doi: 10.1016/j.annonc.2023.04.005. Epub 2023 Apr 24.
4
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images.一种用于量化全切片图像中肿瘤浸润淋巴细胞的实用机器学习方法。
Cancers (Basel). 2022 Jun 16;14(12):2974. doi: 10.3390/cancers14122974.
5
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?数字化定量 CD8+细胞:非小细胞肺癌免疫细胞评分的最佳候选标志物?
Carcinogenesis. 2020 Dec 31;41(12):1671-1681. doi: 10.1093/carcin/bgaa105.
6
Artificial intelligence as the next step towards precision pathology.人工智能作为迈向精准病理学的下一步。
J Intern Med. 2020 Jul;288(1):62-81. doi: 10.1111/joim.13030. Epub 2020 Mar 3.
7
Hover-Net: Simultaneous segmentation and classification of nuclei in multi-tissue histology images.Hover-Net:多组织组织学图像中细胞核的同时分割和分类。
Med Image Anal. 2019 Dec;58:101563. doi: 10.1016/j.media.2019.101563. Epub 2019 Sep 18.
8
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.肿瘤浸润淋巴细胞与预后:早期三阴性乳腺癌患者的汇总分析。
J Clin Oncol. 2019 Mar 1;37(7):559-569. doi: 10.1200/JCO.18.01010. Epub 2019 Jan 16.
9
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.TCGA 泛癌临床数据资源整合,推动高质量生存预后分析。
Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.
10
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.LAG-3 在非小细胞肺癌中的表达:原发肿瘤和转移淋巴结中的表达与生存改善相关。
Clin Lung Cancer. 2018 May;19(3):249-259.e2. doi: 10.1016/j.cllc.2017.12.001. Epub 2017 Dec 11.